About
8.03USD+0.04 +0.50%
Closed • Updated at 13:14 GMT+00:00Market Cap$1.76B
Volume4.66M
Beta1.07
RSI33.51
Gross Margin87.24%
Ocular Therapeutix, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 5 2026
Ocular Therapeutix™ Reports First Quarter 2026 Financial Results and Business Highlights
Apr 29 2026
Ocular Therapeutix™ Announces First Patient Enrolled in SOL-X Long-Term Extension Trial for AXPAXLI™ in Wet AMD
Apr 28 2026
Ocular Therapeutix™ to Report First Quarter 2026 Financial Results on May 5, 2026
Apr 27 2026
Ocular Therapeutix™ to Participate in May Scientific and Investor Conferences
Apr 22 2026
Ocular Therapeutix™ to Host Investor Day on June 17, 2026
Translate